SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-023335
Filing Date
2023-08-11
Accepted
2023-08-11 16:25:06
Documents
50
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atxi20230630_10q.htm   iXBRL 10-Q 953060
2 EXHIBIT 31.1 ex_522419.htm EX-31.1 12829
3 EXHIBIT 31.2 ex_522420.htm EX-31.2 12806
4 EXHIBIT 32.1 ex_522421.htm EX-32.1 4803
5 EXHIBIT 32.2 ex_522422.htm EX-32.2 4869
  Complete submission text file 0001437749-23-023335.txt   4504466

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atxi-20230630.xsd EX-101.SCH 46223
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20230630_cal.xml EX-101.CAL 22944
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20230630_def.xml EX-101.DEF 286126
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20230630_lab.xml EX-101.LAB 282619
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20230630_pre.xml EX-101.PRE 306919
44 EXTRACTED XBRL INSTANCE DOCUMENT atxi20230630_10q_htm.xml XML 648347
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 231164488
SIC: 2834 Pharmaceutical Preparations